SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis
USES SKYRIZI is a prescription medicine used to treat adults with: moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV …
Top 5 Most-Read Gastroenterology Articles of 2025
4 days ago · In a significant market shift concerning biologics used to treat conditions like Crohn disease and ulcerative colitis, AbbVie’s Skyrizi (risankizumab-rzaa) officially surpassed Humira (reference …
Which Biologics Treat Ulcerative Colitis (UC)? - GoodRx
Dec 18, 2025 · Skyrizi lessens gut inflammation by blocking IL-23p19, similarly to Omvoh. However, unlike Omvoh, Skyrizi is approved to treat both forms of inflammatory bowel disease (IBD) — …
Promising Therapeutic Options for Ulcerative Colitis Treatment
Jul 14, 2025 · In ulcerative colitis treatment options, the addition of SKYRIZI has helped AbbVie strengthen its IBD portfolio. SKYRIZI and RINVOQ are performing exceptionally well and are …
FDA Approval of Risankizumab: A New Era for Ulcerative ...
Jun 2, 2025 · As gastroenterologists navigate the unmet needs of refractory ulcerative colitis, the FDA approval of risankizumab for ulcerative colitis marks a watershed moment, introducing the first IL-23 …
Biologics for Ulcerative Colitis: 7 Best Options - Liv Hospital
This ultimate guide reviews the 7 best biologics for ulcerative colitis. Compare proven options like Humira, Remicade, and Entyvio.
Risankizumab-rzaa (SKYRIZI) in Ulcerative Colitis Criteria for Use February 2025 VA Pharmacy Benefits Management Services and National Formulary Committee The following recommendations are …
Skyrizi for Ulcerative Colitis - HealthCentral
Jul 23, 2024 · As a treatment for ulcerative colitis, Skyrizi works by fighting the inflammation that can lead to symptoms of the disease.
Risankizumab for Ulcerative Colitis - JAMA Network
Jul 22, 2024 · Abstract Importance The clinical effects of risankizumab (a monoclonal antibody that selectively targets the p19 subunit of IL-23) for the treatment of ulcerative colitis are unknown. …
Ulcerative Colitis Treatment - SKYRIZI® (risankizumab-rzaa)
SKYRIZI® is indicated for the treatment of moderately to severely active ulcerative colitis in adults. See Important Safety and Prescribing Information.